Pregabalin for anxiety comorbidity in patients with schizophrenia (PACS) - A Double-blinded Randomized Placebo Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 20 Feb 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Anxiety disorders
- Focus Therapeutic Use
- Acronyms PACS
- 06 Jan 2017 Status changed from recruiting to completed.
- 07 Jan 2016 Planned End Date changed from 1 Feb 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 07 Jan 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov record.